Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Electroconvulsive Therapy While Receiving OralAnticoagulation for Deep Venous Thrombosis:Report on Eight Cases and a Review of theLiterature.

Hirata T, Yasuda K, Uemura T, Ohtsuki M, Kobayashi K, Ueda T, Aruga Y, Tamaoki T, Suzuki T.

Psychosomatics. 2019 Jul - Aug;60(4):402-409. doi: 10.1016/j.psym.2018.10.007. Epub 2018 Nov 7.

PMID:
30503364
2.

Poland syndrome accompanied by internal iliac artery supply disruption sequence: a case report.

Gonda K, Tachiya Y, Hatakeyama Y, Momma T, Tamaoki T, Maejima Y, Rokkaku Y, Saji S, Shimomura K, Kono K.

J Med Case Rep. 2018 Oct 26;12(1):312. doi: 10.1186/s13256-018-1823-8.

3.

Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression.

Yamazaki C, Tamaoki T, Nunomura A, Tamai K, Yasuda K, Motohashi N.

J Alzheimers Dis. 2017;58(2):349-354. doi: 10.3233/JAD-170111.

PMID:
28453490
4.

Nutritional status of patients with phenylketonuria in Japan.

Okano Y, Hattori T, Fujimoto H, Noi K, Okamoto M, Watanabe T, Watanabe R, Fujii R, Tamaoki T.

Mol Genet Metab Rep. 2016 Aug 20;8:103-10. doi: 10.1016/j.ymgmr.2016.08.005. eCollection 2016 Sep.

5.

Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.

Kita S, Matsubara H, Kasai Y, Tamaoki T, Okabe Y, Fukuhara H, Kamishikiryo J, Krayukhina E, Uchiyama S, Ose T, Kuroki K, Maenaka K.

Eur J Immunol. 2015 Jun;45(6):1605-13. doi: 10.1002/eji.201545509. Epub 2015 Apr 28.

6.

[Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].

Nunomura A, Tamaoki T, Motohashi N.

Seishin Shinkeigaku Zasshi. 2014;116(10):842-58. Japanese.

PMID:
25672211
7.

TGF- β Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the α -Fetoprotein Promoter.

Sakata N, Kaneko S, Ikeno S, Miura Y, Nakabayashi H, Dong XY, Dong JT, Tamaoki T, Nakano N, Itoh S.

J Signal Transduct. 2014;2014:970346. doi: 10.1155/2014/970346. Epub 2014 Jul 3.

8.

Seizure threshold and the half-age method in bilateral electroconvulsive therapy in Japanese patients.

Yasuda K, Kobayashi K, Yamaguchi M, Tanaka K, Fujii T, Kitahara Y, Tamaoki T, Matsushita Y, Nunomura A, Motohashi N.

Psychiatry Clin Neurosci. 2015 Jan;69(1):49-54. doi: 10.1111/pcn.12225. Epub 2014 Sep 12.

9.

Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis.

Tsunemi S, Iwasaki T, Kitano S, Matsumoto K, Takagi-Kimura M, Kubo S, Tamaoki T, Sano H.

Arthritis Res Ther. 2013 Jul 22;15(4):R75. doi: 10.1186/ar4252.

10.

[Vascular cognitive impairment].

Nunomura A, Tamaoki T.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:325-30. Review. Japanese. No abstract available.

PMID:
22755207
11.

C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan.

Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, Kuzuhara S, Ranum LP, Tamaoki T, Ichikawa Y, Date H, Goto J, Tsuji S.

Arch Neurol. 2012 Sep;69(9):1154-8. doi: 10.1001/archneurol.2012.1219.

PMID:
22637429
12.

The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X.

J Neuropathol Exp Neurol. 2012 Mar;71(3):233-41. doi: 10.1097/NEN.0b013e318248e614.

13.

Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Murakami A, Fujimori Y, Yoshikawa Y, Yamada S, Tamura K, Hirayama N, Terada T, Kuribayashi K, Tabata C, Fukuoka K, Tamaoki T, Nakano T.

Lung. 2012 Jun;190(3):333-7. doi: 10.1007/s00408-012-9371-2. Epub 2012 Jan 21.

PMID:
22271370
14.

Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.

Nunomura A, Tamaoki T, Tanaka K, Motohashi N, Nakamura M, Hayashi T, Yamaguchi H, Shimohama S, Lee HG, Zhu X, Smith MA, Perry G.

Neurobiol Dis. 2010 Mar;37(3):731-7. doi: 10.1016/j.nbd.2009.12.012. Epub 2009 Dec 23.

15.

Efficacy of punctum plug treatment in short break-up time dry eye.

Kaido M, Ishida R, Dogru M, Tamaoki T, Tsubota K.

Optom Vis Sci. 2008 Aug;85(8):758-63. doi: 10.1097/OPX.0b013e3181819f0a.

PMID:
18677228
16.

[Examination of R-L shunt ratio mensuration using dynamic images in lung perfusion scintigraphy].

Ichikawa H, Yamada S, Yoshioka C, Tamaoki T, Miura S, Suzuki M, Makino T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2008 May 20;64(5):579-86. Japanese.

17.

[Other treatments for depressive patients].

Tamaoki T, Motohashi N.

Nihon Rinsho. 2007 Sep;65(9):1655-9. Review. Japanese.

PMID:
17876990
18.

A homeodomain-zinc finger protein, ZFHX4, is expressed in neuronal differentiation manner and suppressed in muscle differentiation manner.

Hemmi K, Ma D, Miura Y, Kawaguchi M, Sasahara M, Hashimoto-Tamaoki T, Tamaoki T, Sakata N, Tsuchiya K.

Biol Pharm Bull. 2006 Sep;29(9):1830-5.

19.

Impairment of theory of mind in patients in remission following first episode of schizophrenia.

Inoue Y, Yamada K, Hirano M, Shinohara M, Tamaoki T, Iguchi H, Tonooka Y, Kanba S.

Eur Arch Psychiatry Clin Neurosci. 2006 Aug;256(5):326-8.

PMID:
16927040
20.

c-Myb inhibits myogenic differentiation through repression of MyoD.

Kaspar P, Pajer P, Sedlak D, Tamaoki T, Dvorak M.

Exp Cell Res. 2005 Oct 1;309(2):419-28.

PMID:
16055116
21.

Avoiding the effect of linked genes is crucial to elucidate the role of Apcs in autoimmunity.

Tamaoki T, Tezuka H, Okada Y, Ito S, Shimura H, Sakamoto M, Endo T, Ozaki Y, Kanba S, Maeda S.

Nat Med. 2005 Jan;11(1):11-2; author reply 12-3. No abstract available.

PMID:
15635430
22.

A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.

Tomizawa M, Yu L, Wada A, Tamaoki T, Kadomatsu K, Muramatsu T, Matsubara S, Watanabe K, Ebara M, Saisho H, Sakiyama S, Tagawa M.

Br J Cancer. 2003 Sep 15;89(6):1086-90.

23.

ATBF1-A protein, but not ATBF1-B, is preferentially expressed in developing rat brain.

Ishii Y, Kawaguchi M, Takagawa K, Oya T, Nogami S, Tamura A, Miura Y, Ido A, Sakata N, Hashimoto-Tamaoki T, Kimura T, Saito T, Tamaoki T, Sasahara M.

J Comp Neurol. 2003 Oct 6;465(1):57-71.

PMID:
12926016
24.

Synthesis and antitumor activity of novel C-8 ester derivatives of leinamycin.

Kanda Y, Ashizawa T, Kawashima K, Ikeda S, Tamaoki T.

Bioorg Med Chem Lett. 2003 Feb 10;13(3):455-8.

PMID:
12565949
25.

Inhibition of lymphocyte kinase Lck and phosphatidylinositol 3-kinase by a novel immunosuppressant, lymphostin.

Nagata H, Yano H, Sasaki K, Sato S, Nakanishi S, Takahashi I, Tamaoki T.

Biosci Biotechnol Biochem. 2002 Mar;66(3):501-7.

26.

Stereospecific antitumor activity of radicicol oxime derivatives.

Soga S, Sharma SV, Shiotsu Y, Shimizu M, Tahara H, Yamaguchi K, Ikuina Y, Murakata C, Tamaoki T, Kurebayashi J, Schulte TW, Neckers LM, Akinaga S.

Cancer Chemother Pharmacol. 2001 Dec;48(6):435-45.

PMID:
11800023
27.

Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.

Ninomiya T, Mihara K, Fushimi K, Hayashi Y, Hashimoto-Tamaoki T, Tamaoki T.

Hepatology. 2002 Jan;35(1):82-7.

PMID:
11786962
28.

DNA/RNA-dependent ATPase activity is associated with ATBF1, a multiple homeodomain-zinc finger protein.

Kawaguchi M, Miura Y, Ido A, Morinaga T, Sakata N, Oya T, Hashimoto-Tamaoki T, Sasahara M, Koizumi F, Tamaoki T.

Biochim Biophys Acta. 2001 Dec 17;1550(2):164-74.

PMID:
11755205
29.

Gene therapy vectors harboring AFP regulatory sequences. Preparation of an adenoviral vector.

Kaneko S, Tamaoki T.

Mol Biotechnol. 2001 Nov;19(3):323-30.

PMID:
11721628
30.

Expression of interleukin-18 and its receptor in mouse ovary.

Tsuji Y, Tamaoki TH, Hasegawa A, Kashiwamura S, Iemoto A, Ueda H, Muranaka J, Adachi S, Furuyama J, Okamura H, Koyama K.

Am J Reprod Immunol. 2001 Nov;46(5):349-57.

PMID:
11712764
31.

Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease.

Soma M, Tamaoki T, Kawano H, Ito S, Sakamoto M, Okada Y, Ozaki Y, Kanba S, Hamada Y, Ishihara T, Maeda S.

Biochem Biophys Res Commun. 2001 Aug 10;286(1):200-5.

PMID:
11485329
32.
33.

HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.

Hirano T, Kaneko S, Kaneda Y, Saito I, Tamaoki T, Furuyama J, Tamaoki T, Kobayashi K, Ueki T, Fujimoto J.

Gene Ther. 2001 Jan;8(1):80-3.

34.

UCS15A, a non-kinase inhibitor of Src signal transduction.

Sharma SV, Oneyama C, Yamashita Y, Nakano H, Sugawara K, Hamada M, Kosaka N, Tamaoki T.

Oncogene. 2001 Apr 19;20(17):2068-79.

35.

Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.

Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T, Itoh M.

Oncogene. 2001 Feb 15;20(7):869-73.

36.

Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1.

Berry FB, Miura Y, Mihara K, Kaspar P, Sakata N, Hashimoto-Tamaoki T, Tamaoki T.

J Biol Chem. 2001 Jul 6;276(27):25057-65. Epub 2001 Apr 18.

37.

Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.

Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.

Cancer Res. 2001 Apr 1;61(7):3016-21.

38.

KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models.

Shirai A, Ikeda J, Kawashima S, Tamaoki T, Kamiya T.

J Dermatol Sci. 2001 Apr;25(3):213-8.

PMID:
11240269
39.

Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.

Sakai Y, Kaneko S, Sato Y, Kanegae Y, Tamaoki T, Saito I, Kobayashi K.

J Virol Methods. 2001 Mar;92(1):5-17.

PMID:
11164913
40.

Cloning and characterization of a novel RNA-binding protein SRL300 with RS domains.

Sawada Y, Miura Y, Umeki K, Tamaoki T, Fujinaga K, Ohtaki S.

Biochim Biophys Acta. 2000 Jun 21;1492(1):191-5.

PMID:
11004489
41.

Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.

Shinohara H, Zhou J, Yoshikawa K, Yazumi S, Ko K, Yamaoka Y, Mizukami T, Yoshida T, Akinaga S, Tamaoki T, Motoda H, Benedict WF, Takahashi R.

Br J Cancer. 2000 Oct;83(8):1039-46.

42.
43.

The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.

Sakata N, Hemmi K, Kawaguchi M, Miura Y, Noguchi S, Ma D, Sasahara M, Kato T, Hori M, Tamaoki T.

Biochem Biophys Res Commun. 2000 Jul 5;273(2):686-93.

PMID:
10873665
44.

Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia.

Shiotsu Y, Yamashita K, Kanai F, Ikuina Y, Murakata C, Teramura M, Mizoguchi H, Tamaoki T, Akinaga S.

Blood. 2000 Jun 15;95(12):3771-80.

45.

Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells.

Sasaki K, Tamura S, Tachibana H, Sugita M, Gao Y, Furuyama J, Kakishita E, Sakai T, Tamaoki T, Hashimoto-Tamaoki T.

Brain Res Mol Brain Res. 2000 May 5;77(2):209-21.

PMID:
10837916
46.
47.

Synthesis and antitumor activity of duocarmycin derivatives: modification at C-8 position of A-ring pyrrole compounds bearing the simplified DNA-binding groups.

Amishiro N, Nagamura S, Murakata C, Okamoto A, Kobayashi E, Asada M, Gomi K, Tamaoki T, Okabe M, Yamaguchi N, Yamaguchi K, Saito H.

Bioorg Med Chem. 2000 Feb;8(2):381-91.

PMID:
10722161
48.

UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation.

Sugiyama K, Shimizu M, Akiyama T, Tamaoki T, Yamaguchi K, Takahashi R, Eastman A, Akinaga S.

Int J Cancer. 2000 Mar 1;85(5):703-9.

49.

[Study of the molecular bases of familial amyloidotic polyneuropathy].

Maeda S, Tamaoki T.

No To Shinkei. 2000 Jan;52(1):14-24. Review. Japanese. No abstract available.

PMID:
10689686

Supplemental Content

Loading ...
Support Center